Aurora Denver Cardiology Associates

Aurora, Colorado 80218

2 studies enrolling now · 22 studies all time

What they study most

Acute Coronary Syndrome, Angina Pectoris, Arrhythmia, Arthritis, Rheumatoid, Atherosclerotic Cardiovascular Disease, Atrial Fibrillation, Atrial Septal Defect, Heart Failure, Heart Failure With Preserved Ejection Fraction, Hypertension, Intermittent Claudication, Paroxysmal Atrial Fibrillation

Studies at this site

• A Study of VARIPULSE Catheter in Participants With Persistent Atrial Fibrillation Undergoing Pulmonary Vein and Superior Vena Cava Isolation — Recruiting now
• A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System — Recruiting now
• Real-World Experience - Barostim™ Advancing the Level of Clinical Evidence (REBALANCE Registry) — Stopped early
• Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease — Running, not enrolling
• A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation — Running, not enrolling
• ADAPT - A Patient Registry of the Real-world Use of Orenitram® — Running, not enrolling
• Post Approval Study (PAS) of the OPTIMIZER Smart and CCM Therapy — Running, not enrolling
• Management of LDL-cholesterol With Inclisiran + Usual Care Compared to Usual Care Alone in Participants With a Recent Acute Coronary Syndrome — Completed
• Symptomatic CRT Patients: Real-World Experience - Barostim™ Advancing the Level of Clinical Evidence — Stopped early
• Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation — Completed
• Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen — Completed
• Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction — Stopped early
• Open-label Extension of Oral Treprostinil in Subjects With PH Associated With HFpEF — Stopped early
• Evaluation of Cilostazol in Combination With L-Carnitine — Completed
• Closure of Atrial Septal Defects With the AMPLATZER Septal Occluder - Post Approval Study — Completed
• Diagnostic Device Risk Management of Atrial Fibrillation and Heart Failure — Completed
• DORADO-AC - Optimized Doses of Darusentan as Compared to an Active Control in Resistant Hypertension — Completed
• DORADO-AC-EX - A Long-Term Safety Extension Study to the Phase 3 DORADOC-AC Study (Protocol DAR-312) of Darusentan in Resistant Hypertension — Stopped early
• Establishing a Standard for Peri-operative Implantable Cardioverter Defibrillator (ICD) Patient Education — Completed
• Study of HD Mesh Ablation System for Treatment of Paroxysmal Atrial Fibrillation — Stopped early
• Evaluating the Use of SR34006 Compared to Warfarin or Acenocoumarol in Patients With Atrial Fibrillation (AMADEUS) — Completed
• To Find the Best Dose of pVGI.1(VEGF2) to Benefit Angina Patients When Given With an Experimental Injection Catheter — Status unconfirmed